This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gladson, C. L. Articles by Yacoub, I. Z. Search for Related Content PubMed PubMed Citation Articles by Gladson, C. L. Articles by Yacoub, I. Z.

American Journal of Pathology, Vol 146, 1150-1160, Copyright © 1995 by American Society for Investigative Pathology

REGULAR ARTICLES

Up-regulation of urokinase and urokinase receptor genes in malignant astrocytoma

CL Gladson, V Pijuan-Thompson, MA Olman, GY Gillespie and IZ Yacoub
Department of Pathology, University of Alabama at Birmingham 35294- 0007, USA.

To understand the role of urokinase (u-PA) and the urokinase receptor (u-PAR) in malignant astrocytoma cell invasion of normal brain, astrocytic expression of u-PAR and u-PA mRNAs were analyzed by riboprobe in situ hybridization in astrocytoma and non-neoplastic brain biopsies. In eight of eight malignant astrocytomas (glioblastomas), u- PAR and u-PA mRNA expression was demonstrated, whereas in seven non- neoplastic brain biopsies, u-PAR and u-PA mRNAs were not expressed. In one of four low grade and all anaplastic astrocytomas u-PAR mRNA was expressed, although u-PA mRNA was undetectable. Consistent with the mRNA detection, u-PAR and u-PA proteins were expressed by malignant astrocytes in five of five glioblastoma biopsies. To study the tumor margin, U-251MG glioblastoma cells were propagated intracerebrally in a severe combined immunodeficient mouse xenograft (28 days), and u-PA mRNA was found to localize predominantly to the leading tumor edge, whereas u-PAR mRNA was expressed throughout the tumor. Furthermore, adherent human U-251MG glioblastoma cells in vitro expressed u-PAR and u-PA proteins, which localized to sites of integrin alpha nu beta 3 cell-matrix contacts. These data indicate that co-expression of u-PAR and u-PA mRNAs and proteins marks the malignant astrocyte phenotype and that u-PA bound to u-PAR may play a role in glioblastoma cell invasion of normal brain by virtue of its expression at the leading tumor edge.

This article has been cited by other articles:

				C. S. Gondi, S. S. Lakka, D. H. Dinh, W. C. Olivero, M. Gujrati, and J. S. Rao Intraperitoneal Injection of a Hairpin RNA Expressing Plasmid Targeting Urokinase-Type Plasminogen Activator (uPA) Receptor and uPA Retards Angiogenesis and Inhibits Intracranial Tumor Growth in Nude Mice Clin. Cancer Res., July 15, 2007; 13(14): 4051 - 4060. [Abstract] [Full Text] [PDF]

				C. S. Gondi, N. Kandhukuri, S. Kondraganti, M. Gujrati, W. C. Olivero, D. H. Dinh, and J. S. Rao RNA interference-mediated simultaneous down-regulation of urokinase-type plasminogen activator receptor and cathepsin B induces caspase-8-mediated apoptosis in SNB19 human glioma cells Mol. Cancer Ther., December 1, 2006; 5(12): 3197 - 3208. [Abstract] [Full Text] [PDF]

				D. Chen, A. Kennedy, J.-Y. Wang, W. Zeng, Q. Zhao, M. Pearl, M. Zhang, Z. Suo, J. M. Nesland, Y. Qiao, et al. Activation of EDTA-Resistant Gelatinases in Malignant Human Tumors. Cancer Res., October 15, 2006; 66(20): 9977 - 9985. [Abstract] [Full Text] [PDF]

				W. Debinski and D. M. Gibo Fos-Related Antigen 1 Modulates Malignant Features of Glioma Cells Mol. Cancer Res., April 1, 2005; 3(4): 237 - 249. [Abstract] [Full Text] [PDF]

				C. S. Gondi, S. S. Lakka, N. Yanamandra, W. C. Olivero, D. H. Dinh, M. Gujrati, C. H. Tung, R. Weissleder, and J. S. Rao Adenovirus-Mediated Expression of Antisense Urokinase Plasminogen Activator Receptor and Antisense Cathepsin B Inhibits Tumor Growth, Invasion, and Angiogenesis in Gliomas Cancer Res., June 15, 2004; 64(12): 4069 - 4077. [Abstract] [Full Text] [PDF]

				S. S. Lakka, C. S. Gondi, N. Yanamandra, D. H. Dinh, W. C. Olivero, M. Gujrati, and J. S. Rao Synergistic Down-Regulation of Urokinase Plasminogen Activator Receptor and Matrix Metalloproteinase-9 in SNB19 Glioblastoma Cells Efficiently Inhibits Glioma Cell Invasion, Angiogenesis, and Tumor Growth Cancer Res., May 15, 2003; 63(10): 2454 - 2461. [Abstract] [Full Text] [PDF]

				Y. Adachi, S. S. Lakka, N. Chandrasekar, N. Yanamandra, C. S. Gondi, S. Mohanam, D. H. Dinh, W. C. Olivero, M. Gujrati, T. Tamiya, et al. Down-regulation of Integrin alpha vbeta 3 Expression and Integrin-mediated Signaling in Glioma Cells by Adenovirus-mediated Transfer of Antisense Urokinase-type Plasminogen Activator Receptor (uPAR) and Sense p16 Genes J. Biol. Chem., December 7, 2001; 276(50): 47171 - 47177. [Abstract] [Full Text] [PDF]

				S. Mohanam, S. L. Jasti, S. R. Kondraganti, N. Chandrasekar, Y. Kin, G. N. Fuller, S. S. Lakka, A. P. Kyritsis, D. H. Dinh, W. C. Olivero, et al. Stable Transfection of Urokinase-Type Plasminogen Activator Antisense Construct Modulates Invasion of Human Glioblastoma Cells Clin. Cancer Res., August 1, 2001; 7(8): 2519 - 2526. [Abstract] [Full Text] [PDF]

				S. S. Lakka, R. Rajagopal, M. K. Rajan, P. M. Mohan, Y. Adachi, D. H. Dinh, W. C. Olivero, M. Gujrati, F. Ali-Osman, J. A. Roth, et al. Adenovirus-mediated Antisense Urokinase-Type Plasminogen Activator Receptor Gene Transfer Reduces Tumor Cell Invasion and Metastasis in Non-Small Cell Lung Cancer Cell Lines Clin. Cancer Res., April 1, 2001; 7(4): 1087 - 1093. [Abstract] [Full Text]

				A. Bhattacharya, S. S. Lakka, S. Mohanam, D. Boyd, and J. S. Rao Regulation of the Urokinase-type Plasminogen Activator Receptor Gene in Different Grades of Human Glioma Cell Lines Clin. Cancer Res., February 1, 2001; 7(2): 267 - 276. [Abstract] [Full Text]

				V. Rajagopal and R. J. Kreitman Recombinant Toxins That Bind to the Urokinase Receptor Are Cytotoxic without Requiring Binding to the alpha 2-Macroglobulin Receptor J. Biol. Chem., March 10, 2000; 275(11): 7566 - 7573. [Abstract] [Full Text] [PDF]

				P. M. Mohan, S. K. Chintala, S. Mohanam, C. L. Gladson, E. So Kim, Z. L. Gokaslan, S. S. Lakka, J. A. Roth, B. Fang, R. Sawaya, et al. Adenovirus-mediated Delivery of Antisense Gene to Urokinase-type Plasminogen Activator Receptor Suppresses Glioma Invasion and Tumor Growth Cancer Res., July 1, 1999; 59(14): 3369 - 3373. [Abstract] [Full Text] [PDF]

				K. Mishima, A. P. Mazar, A. Gown, M. Skelly, X.-D. Ji, X.-D. Wang, T. R. Jones, W. K. Cavenee, and H.-J. S. Huang A peptide derived from the non-receptor-binding region of urokinase plasminogen activator inhibits glioblastoma growth and angiogenesis in vivo in combination with cisplatin PNAS, July 18, 2000; 97(15): 8484 - 8489. [Abstract] [Full Text] [PDF]